Effects of Serum Leptin and Resistin Levels on Cancer Cachexia in Patients With Advanced-Stage Non-Small Cell Lung Cancer
- PMID: 28469508
- PMCID: PMC5395268
- DOI: 10.1177/1179554917690144
Effects of Serum Leptin and Resistin Levels on Cancer Cachexia in Patients With Advanced-Stage Non-Small Cell Lung Cancer
Abstract
Introduction: Cancer cachexia is one of the most frequent effects of malignancy, is often associated with poor prognosis, and may account for up to 20% of cancer deaths. The aim of our study was to evaluate the relationship of cancer cachexia and serum levels of resistin and leptin in patients with advanced non-small cell lung cancer.
Methods: A total of 67 chemotherapy-naïve patients with advanced-stage non-small cell cancer and a control group containing 20 healthy individuals without a known chronic disease were enrolled in this study. All individuals in the control group were age and sex matched. Demographic, anthropometric, laboratory data and serum levels of adipokines were measured for 2 groups. Progression-free survival and overall survival were estimated using the Kaplan-Meier method. Survival among various factors was calculated using the log-rank test.
Results: Patients presented significantly higher serum resistin (P = .0001) and lower serum leptin levels (P = .025) than the control group. Lower serum levels of leptin were correlated with overall survival (P = .011).
Conclusions: Serum leptin and resistin levels play key role as proinflammatory cytokines in lung cancer and cancer cachexia; however, their use as diagnostic or prognostic markers is not possible yet, and further large-scale studies are required to confirm our findings.
Keywords: cancer cachexia; leptin; lung cancer; resistin.
Conflict of interest statement
DECLARATION OF CONFLICTING INTERESTS: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
Figures
Similar articles
-
The significance of leptin, adiponectin, and resistin serum levels in non-small cell lung cancer (NSCLC).Lung Cancer. 2008 Sep;61(3):391-7. doi: 10.1016/j.lungcan.2008.01.018. Epub 2008 Mar 14. Lung Cancer. 2008. PMID: 18342391
-
Adipokines in patients with cancer anorexia and cachexia.J Investig Med. 2010 Mar;58(3):554-9. doi: 10.231/JIM.0b013e3181cf91ca. J Investig Med. 2010. PMID: 20215915
-
Serum values of proinflammatory cytokines are inversely correlated with serum leptin levels in patients with advanced stage cancer at different sites.J Mol Med (Berl). 2001 Jul;79(7):406-14. doi: 10.1007/s001090100234. J Mol Med (Berl). 2001. PMID: 11466563
-
Hormones of adipose tissue and their biologic role in lung cancer.Cancer Treat Rev. 2014 Feb;40(1):22-30. doi: 10.1016/j.ctrv.2013.06.005. Epub 2013 Jul 16. Cancer Treat Rev. 2014. PMID: 23870486 Review.
-
Association of circulating resistin, leptin, adiponectin and visfatin levels with Behçet disease: a meta-analysis.Clin Exp Dermatol. 2018 Jul;43(5):536-545. doi: 10.1111/ced.13383. Epub 2018 Jan 22. Clin Exp Dermatol. 2018. PMID: 29356069 Review.
Cited by
-
Novel oncogenic and chemoresistance-inducing functions of resistin in ovarian cancer cells require miRNAs-mediated induction of epithelial-to-mesenchymal transition.Sci Rep. 2018 Aug 21;8(1):12522. doi: 10.1038/s41598-018-30978-6. Sci Rep. 2018. PMID: 30131543 Free PMC article.
-
Toward a holistic understanding of cancer cachexia: Application of the human response to illness model.Asia Pac J Oncol Nurs. 2023 Sep 5;10(Suppl 1):100306. doi: 10.1016/j.apjon.2023.100306. eCollection 2023 Nov. Asia Pac J Oncol Nurs. 2023. PMID: 38197036 Free PMC article. Review.
-
Effect of Leptin on Chronic Inflammatory Disorders: Insights to Therapeutic Target to Prevent Further Cardiovascular Complication.Diabetes Metab Syndr Obes. 2021 Jul 17;14:3307-3322. doi: 10.2147/DMSO.S321311. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34305402 Free PMC article. Review.
-
Evaluation of Serum Resistin, Visfatin, and Chemerin Levels in Patients with Lung Cancer and Chronic Obstructive Pulmonary Disease.Turk Thorac J. 2020 May;21(3):169-173. doi: 10.5152/TurkThoracJ.2019.19001. Turk Thorac J. 2020. PMID: 32584233 Free PMC article.
-
Leptin induces epithelial-to-mesenchymal transition via activation of the ERK signaling pathway in lung cancer cells.Oncol Lett. 2018 Oct;16(4):4782-4788. doi: 10.3892/ol.2018.9230. Epub 2018 Jul 30. Oncol Lett. 2018. PMID: 30250542 Free PMC article.
References
-
- Fortunati N, Manti R, Birocco N, et al. Pro-inflammatory cytokines and oxidative stress/antioxidant parameters characterize the bio-humoral profile of early cachexia in lung cancer patients. Oncol Rep. 2007;18:1521–1527. - PubMed
-
- Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care. 2005;8:265–269. - PubMed
-
- Johnson G, Salle A, Lorimier G, et al. Cancer cachexia: measured and predicted resting energy expenditures for nutritional needs evaluation. Nutrition. 2008;24:443–450. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources